ClinicalTrials.Veeva

Menu

CO Monitoring for Tobacco Cessation in Quitlines

C

Consumer Wellness Solutions

Status and phase

Completed
Phase 2
Phase 1

Conditions

Tobacco Dependence

Treatments

Combination Product: Remote Carbon Monoxide (CO) Monitoring
Combination Product: Quitline Treatment as Usual (TAU)
Combination Product: Incentivized Remote CO Monitoring

Study type

Interventional

Funder types

Industry
Other

Identifiers

NCT05327660
2021-0056

Details and patient eligibility

About

The present study is a 3-arm randomized controlled pilot study. Participants who call the Maryland Tobacco Quitline and are eligible for study participation are randomized to receive quitline tobacco cessation treatment as usual (TAU), TAU plus remote carbon monoxide (CO) monitoring via smartphone app, or TAU plus remote carbon monoxide monitoring plus incentives vis smartphone app. The investigators hypothesize that remote CO monitoring will be feasible and acceptable to deliver in the quitline setting, will increase treatment engagement, and will increase tobacco cessation and treatment satisfaction rates.

Enrollment

229 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Daily cigarette smokers calling into participating quitlines
  • 18 year or older
  • Reads and speaks English
  • Has a smartphone with a data plan
  • Willing to download and use study app
  • Willing to use CO monitor

Exclusion criteria

• Pregnant or breast feeding

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

229 participants in 3 patient groups

Quitline treatment as usual (TAU)
Active Comparator group
Description:
Quitline services provided by participating state quitlines
Treatment:
Combination Product: Quitline Treatment as Usual (TAU)
Quitline TAU plus remote CO monitoring
Experimental group
Description:
Quitline service plus daily CO monitoring via a smartphone app
Treatment:
Combination Product: Quitline Treatment as Usual (TAU)
Combination Product: Remote Carbon Monoxide (CO) Monitoring
Quitline TAU plus incentivized remote CO monitoring
Experimental group
Description:
Quitline TAU plus remote CO monitoring with small monetary incentives
Treatment:
Combination Product: Incentivized Remote CO Monitoring
Combination Product: Quitline Treatment as Usual (TAU)

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Kelly Carpenter, PhD; Caryn Chalmers, MPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems